Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Skaltsas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Research|December 23, 2020
Assessing Drug Development Risk Using Big Data and Machine LearningVangelis Vergetis, Dimitrios Skaltsas, Vassilis G Gorgoulis, et al.
Cell Reports Methods|March 20, 2023
Machine learning approaches to predict drug efficacy and toxicity in oncologyBara A Badwan, Gerry Liaropoulos, Efthymios Kyrodimos, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 14, 2025
In Situ and In Silico Methods for Senescence Identification in Human Liver DiseasesKonstantinos Evangelou, Konstantinos Belogiannis, Pavlos Pantelis, et al.
Contemporary Clinical Trials Communications|January 19, 2026
Strategic risk assessment in oncology: Utilizing single-agent activity to boost combination therapy approvalsAdetayo Kasim, Marina Anastasiou, Evangelia Loizou, et al.
Molecular Cancer|December 10, 2025
Immune cell senescence drives responsiveness to immunotherapy in melanomaPavlos Pantelis, Dimitrios Christos Tremoulis, Konstantinos Evangelou, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Research|December 23, 2020
Assessing Drug Development Risk Using Big Data and Machine LearningVangelis Vergetis, Dimitrios Skaltsas, Vassilis G Gorgoulis, et al.
Cell Reports Methods|March 20, 2023
Machine learning approaches to predict drug efficacy and toxicity in oncologyBara A Badwan, Gerry Liaropoulos, Efthymios Kyrodimos, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 14, 2025
In Situ and In Silico Methods for Senescence Identification in Human Liver DiseasesKonstantinos Evangelou, Konstantinos Belogiannis, Pavlos Pantelis, et al.
Contemporary Clinical Trials Communications|January 19, 2026
Strategic risk assessment in oncology: Utilizing single-agent activity to boost combination therapy approvalsAdetayo Kasim, Marina Anastasiou, Evangelia Loizou, et al.
Molecular Cancer|December 10, 2025
Immune cell senescence drives responsiveness to immunotherapy in melanomaPavlos Pantelis, Dimitrios Christos Tremoulis, Konstantinos Evangelou, et al.
Pageof 1